Pre-clinical study of SYX3759, a novel PARG inhibitor for the treatment of homologous recombination deficient malignancies

被引：0
|
作者：
Tang, Xuzhen
Cui, Yaqi
Zhang, Lanqiao
Jin, Huihui
Xu, Zeqiong
He, Hu
Ge, Chongxun
Liu, Song
Yu, Xiaochun
Shi, Song
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-6184
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6184
引用
收藏
页数：2
相关论文
共 17 条
  • [1] Pre-clinical activity of the PARP inhibitor AZD2281 in homologous recombination repair deficient triple negative breast cancer
    O'Connor, M. J.
    Lau, A.
    Finn, R. S.
    Knights, C.
    O'Shaughnessy, A.
    Kalous, O.
    Conklin, D.
    Riches, L.
    Carmichael, J.
    Slamon, D. J.
    EJC SUPPLEMENTS, 2008, 6 (12): : 175 - 176
  • [2] Identification of DAT-2000A, a novel potent PARG inhibitor that selectively inhibits PARPi-resistant and homologous-recombination-deficient tumors
    Yan, Dan
    Zhang, Yan
    Yu, Zhangqi
    Zhang, Yao
    Zhang, Jingxi
    Wang, Bin
    Chen, Huixian
    Shi, Jingxue
    Bao, Zhiwei
    Lin, Xiaoling
    Zhuo, Jincong
    Zhou, Kevin
    CANCER RESEARCH, 2024, 84 (06)
  • [3] A novel small molecule inhibitor of PARG, YL-18319, promotes tumor regression in BRCAmutated, Homologous Recombination Deficient, and PARP-inhibitor resistant cancer models
    Weaver, D.
    Lou, Y.
    Wild, R.
    Johnson, M.
    Xu, Z.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S135 - S135
  • [4] Pre-clinical evaluation of single-agent activity of the PARP inhibitor olaparib (AZD2281) in homologous recombination deficient triple-negative breast cancer
    Knights, Charlotte
    Riches, Lucy
    Lau, Alan
    Mangena, Ramu
    Avis, Tim
    Finn, Richard
    O'Shaughnessy, Aisling
    Cranston, Aaron
    Kalous, Ondrej
    Conklin, Dylan
    Carmichael, James
    Slamon, Dennis
    O'Connor, Mark
    CANCER RESEARCH, 2009, 69
  • [5] Pre-clinical pharmacodynamic study of a novel oral factor Xa inhibitor zifaxaban
    Qiu, Xiaomiao
    Wang, Weiting
    Zhao, Zhuanyou
    Sun, Shuangyong
    Tang, Lida
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2018, 836 : 50 - 56
  • [6] IDE161, a potential first-in-class clinical candidate PARG inhibitor, selectively targets homologous-recombination-deficient and PARP inhibitor resistant breast and ovarian tumors
    Abed, Monah
    Munoz, Diana
    Seshadri, Vidya
    Federowicz, Steve
    Rao, Arjun A.
    Bhupathi, Deepthi
    Liimatta, Marya
    Ousterhout, Rita
    Jaipuri, Firoz
    Neilan, Claire
    Lackner, Mark
    White, Mike
    Mounir, Zineb
    CANCER RESEARCH, 2023, 83 (07)
  • [7] The Novel Deacetylase Inhibitor AR-42 Demonstrates Pre-Clinical Activity in B-Cell Malignancies In Vitro and In Vivo
    Lucas, David M.
    Alinari, Lapo
    West, Derek A.
    Davis, Melanie E.
    Edwards, Ryan B.
    Johnson, Amy J.
    Blum, Kristie A.
    Hofmeister, Craig C.
    Freitas, Michael A.
    Parthun, Mark R.
    Wang, Dasheng
    Lehman, Amy
    Zhang, Xiaoli
    Jarjoura, David
    Kulp, Samuel K.
    Croce, Carlo M.
    Grever, Michael R.
    Chen, Ching-Shih
    Baiocchi, Robert A.
    Byrd, John C.
    PLOS ONE, 2010, 5 (06):
  • [8] Pre-clinical characterization of RP3128, a novel and potent CRAC channel inhibitor for the treatment of respiratory disorders
    Vakkalanka, Swaroop
    Merikapudi, Gayatriswaroop
    Babu, G.
    Routhu, Kasiviswanath
    Veeraraghavan, Sridhar
    Viswanadha, Srikant
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [9] Pre-clinical Study of BK-UM, a Novel Inhibitor of HB-EGF, for Ovarian Cancer Therapy
    Nam, Sung Ouk
    Yotsumoto, Fusanori
    Miyata, Kohei
    Suzaki, Yuki
    Yagi, Hiroshi
    Odawara, Takashi
    Manabe, Sadao
    Ishikawa, Toyokazu
    Kuroki, Masahide
    Mekada, Eisuke
    Miyamoto, Shingo
    ANTICANCER RESEARCH, 2014, 34 (08) : 4615 - 4620
  • [10] Treatment with the Novel TOPK Inhibitor OTS514 Exhibits Potent Anti-Myeloma Activity in Pre-Clinical Models
    Stefka, Andrew
    Johnson, David
    Rosebeck, Shaun
    Park, Jae-Hyun
    Nakamura, Yusuke
    Jakubowiak, Andrzej J.
    BLOOD, 2017, 130
12